FANAPT (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the FANAPT drug offered from Novartis Pharmaceuticals Corporation. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | Iloperidone |
| SUBSTANCE NAME: | ILOPERIDONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-10-01 |
| END MARKETING DATE: | 0000-00-00 |
FANAPT HUMAN PRESCRIPTION DRUG Details:
| Item Description | FANAPT from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2009-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0595_22ae60cc-b992-4b87-8e70-c217ce57cd0c |
| PRODUCT NDC: | 0078-0595 |
| APPLICATION NUMBER: | NDA022192 |
Other ILOPERIDONE Pharmaceutical Manufacturers / Labelers:
